Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07473232 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparison of Platelet-rich Plasma and Activated Cytokine-rich Serum Injection Treatments in Patients With Knee Osteoarthritis. (KOA PRP ACS)

Study acronym: KOA PRP ACS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 20, 2026 (before its estimated August 30, 2026 completion). Its status may not reflect the trial's current state.
Trial flagged as At Risk
Primary completion moved at least 2 months later Jun 30, 2026 → Aug 30, 2026
See other at-risk trials from Pamukkale University

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened
    • Primary completion pushed from Jun 30, 2026 to Aug 30, 2026
    • Study completion pushed from Jun 30, 2026 to Oct 30, 2026
    • Study sites: 0 to 1
    v3
  2. Interventions: Autologous Platelet-Rich Plasma (PRP) (Other), Conditioned serum (CS) (Other) to Autologous Platelet-Rich Plasma (PRP) (Drug), Conditioned serum (CS) (Drug)
    • Eligibility criteria revised
    • Study description revised
    • Study title expanded, about 4 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The effects of single dose injection of platelet rich plasma or conditioned serum in the knee joint in patients with knee osteoarthritis will be compared
Trial Details
NCT Number NCT07473232
Lead Sponsor Pamukkale University
Conditions
(from sponsor)		 Knee Arthritis Osteoarthritis, Platelet Rich Plasma Injection, Conditioned Serum
Related terms Inflammation, Osteoarthritis, Knee
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov